On June 29, the U.S. House of Representatives passed the Fiscal Year 2018 Department of Defense (DoD) Appropriations bill, which funds the country’s military and medical activities. Within that legislation, $5 million in funding was allocated to the Lupus Research...
In the wake of the much-publicized drug price hikes of common prescriptions such as Mylan’s Epipen and Turing’s Daraprim, patients and doctors alike have been scratching their heads about why drug prices keep increasing. Some reasons may be the rise of the cost of...
In 2017, refinements and improvements for the treatment of rheumatoid arthritis were extended to other ailments as well. This included findings for lupus, psoriatic arthritis, and more. Studies and tests have been done in the attempt to advance biologics, which are...
Patients with gout and clinicians who treat the disease should be aware of a recent Food and Drug Administration Safety Announcement regarding the drug Febuxostat. Commonly known as Uloric or Adenuric, Febuxostat was initially developed by a Japanese pharmaceutical...
It’s not easy to live with arthritis. As time goes on, it becomes necessary to find new ways to deal with painful movements and accomplish daily tasks. The right medications may help slow the disease’s progression while reducing joint damage and other...
